Please login to the form below

Not currently logged in

Roche appoints Pamela Carroll as global head of pathways biology

She will also act as oncology discovery site head at Roche's Nutley, New Jersey research facility

Pamela Carroll has joined Swiss pharmaceutical company Roche as global head of pathways biology within its Pharma Research and Early Development unit.

Carroll will also act as oncology discovery site head at Roche's Nutley, New Jersey research facility.

She first joined the pharma industry in 1999, taking up a position in applied genomics at Bristol-Myers Squibb, and subsequently moved to Merck Research Laboratories as director and department head of cancer pathways.

In 2009 Carroll moved to the Belfer Institute of Applied Cancer Sciences at Dana Farber Cancer Institute, Harvard Medical School, where she was head of research and a member of the senior leadership team.

Mike Burgess, global head oncology, Discovery and Translational Area, and head, large molecule research at Roche, said: "With more than a decade's industry experience concentrated in cancer, Pam has built a reputation for scientific excellence and leadership in the field.

"Her broad knowledge and successful history in leading oncology drug discovery efforts make her is an ideal fit for this position."
As pathways biology head, Carroll will have global responsibility for pathway validation efforts and ensuring Roche's oncology discovery and translational area develops robust preclinical models to evaluate pathways.

Meanwhile, as oncology discovery site head at the Nutley site she will also be responsible for designing and implementing research studies focused on new or improved oncology medicines, including small molecules and biologics.

She will also direct drug discovery research, help develop oncology objectives for Nutley and contribute to the development of the Roche's global discovery oncology strategy.

8th November 2011


Featured jobs

Subscribe to our email news alerts


Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

If you’re not thinking segmentation, you’re not thinking
Having a background in market research I’ve been lucky to work on a number of customer segmentations in my time but working in creative communications it is still too rare...
Improving Outcomes in the Treatment of Opioid Dependence Highlights Report
The 16th annual ‘Improving Outcomes in the Treatment of Opioid Dependence’ (IOTOD)conference took place at the Hilton Madrid Airport hotel on 15–16 May 2018....
Londonvelophobia (fear of cycling in London) – debunked